DRD2 and schizophrenia: Su and colleagues demonstrated that the DISC1 variant R264Q, located within the D2R-binding region, was shown to increase DISC1 affinity for D2R by promoting GSK3 activity, suggesting a possible mechanism by which this common polymorphism could influence aspects of brain function relevant to schizophrenia, which might be explored for the development of novel drug treatments [229].